SOMERSET, N.J. (AP) — SOMERSET, N.J. (AP) — Catalent Inc. (CTLT) on Monday reported a loss of $227 million in its fiscal third quarter.
On a per-share basis, the Somerset, New Jersey-based company said it had a loss of $1.26. Losses, adjusted for one-time gains and costs, came to 9 cents per share.
The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.
The maker of drug delivery technologies posted revenue of $1.04 billion in the period, also topping Street forecasts. Seven analysts surveyed by Zacks expected $930.4 million.
Catalent expects full-year revenue in the range of $4.22 billion to $4.33 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a CTLT">Zacks stock report on CTLT at https://www.zacks.com/ap/CTLT